Announcements and Notices - [Quarterly Results / Overseas Regulatory Announcement - Trading Update / Inside Information]

Hangzhou Tigermed Consulting Co.,Ltd. provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis. Hangzhou Tigermed Consulting offers services worldwide.

2024 Third Quarterly Report

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Articles Of Association

Announcements and Notices - [Results of EGM/SGM / Amendment of Constitutional Documents]

Poll Voting Results Of The 2024 Third Extraordinary
General Meeting Held On October 8, 2024

Financial Statements/ESG Information - [Interim/Half-Year Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hangzhou Tigermed Consulting C (3347 HK)

2024 Third Quarterly Report

Date Of Board Meeting

Articles Of Association

Poll Voting Results Of The 2024 Third Extraordinary General Meeting Held On October 8, 2024

2024 Interim Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)